血清胱抑素C联合尿中性粒细胞明胶酶相关脂质运载蛋白对肝硬化腹水继发急性肾损伤的诊断价值

雷蕾; 李良平; 张虎

doi:10.3969/j.issn.1001-5256.2018.01.021

血清胱抑素C联合尿中性粒细胞明胶酶相关脂质运载蛋白对肝硬化腹水继发急性肾损伤的诊断价值

DOI: 10.3969/j.issn.1001-5256.2018.01.021

1. 四川省医学科学院，四川省人民医院消化内科
2. 四川大学华西医院消化内科

基金项目:

教育部高等学校博士学科点专项科研基金(新教师类)(20130181120041)；

详细信息

中图分类号: R575.2;R692.5
计量
- 文章访问数: 2189
- HTML全文浏览量: 39
- PDF下载量: 448
- 被引次数: 0
出版历程
- 出版日期: 2018-01-20

Value of combined measurement of serum cystatin C and urinary neutrophil gelatinase-associated lipocalin in diagnosis of acute kidney injury secondary to cirrhotic ascites

Department of Gastroenterology, Sichuan Academy of Medical Sciences & Sichuan Provincial People′s Hospital, Chengdu 610072, China)

Research funding:

摘要

摘要:
目的探讨血清胱抑素C（Cys C）联合尿中性粒细胞明胶酶相关脂质运载蛋白（NGAL）检测在肝硬化腹水继发急性肾损伤（AKI）中的临床诊断价值。方法收集2015年1月-2016年6月四川省人民医院收治的105例肝硬化腹水患者的临床资料,将患者分为AKI组（n=56）和非AKI组（n=49）,同时选取健康体检者（n=40）作为对照。观察血清Cys C、尿NGAL、血肌酐（Scr）水平及肾小球滤过率（GFR）等指标。同时将纳入的105例肝硬化腹水患者按照肝功能Child-Pugh分级划分,比较不同Child-Pugh分级患者的血清Cys C、尿NGAL、SCr、GFR变化。计量资料2组间比较采用独立样本t检验;多组间比较采用单因素方差分析,进一步两两比较采用SNK-q检验。计数资料组间比较采用χ2检验。相关性分析采用Pearson相关分析法。结果 AKI组患者血清Cys C水平、尿NGAL浓度与非AKI组和健康对照组相比,差异均有统计学意义（P值均<0.01）。将AKI患者依照肾损伤标准进行分期,分期高者血清Cys C水平、尿NGAL浓度显著高于分期低的患者（P值...
- 肝硬化 /
- 腹水 /
- 急性肾损伤 /
- 胱抑素C /
- 脂笼蛋白质类 /
- 诊断
Abstract:
Objective To investigate the value of combined measurement of serum cystatin C ( Cys C) and urinary neutrophil gelatinase-associated lipocalin ( NGAL) in the diagnosis of AKI secondary to cirrhotic ascites. Methods A total of 105 patients with cirrhotic ascites who were admitted to Sichuan Provincial People's Hospital from January 2015 to June 2016 were enrolled and divided into AKI group with 56 patients and non-AKI group with 49 patients. Meanwhile, 40 healthy persons who underwent physical examination were enrolled as controls. The indices including serum Cys C, urinary NGAL, serum creatinine ( Scr) , and glomerular filtration rate ( GFR) were observed. The 105 patients with cirrhotic ascites were divided into subgroups according to Child-Pugh class, and the changes in serum Cys C, urinary NGAL, Scr, and GFR were compared between these subgroups. The independent samples t-test was used for comparison of continuous data between two groups; a one-way analysis of variance was used for comparison between multiple groups, and the SNK-q test was used for further comparison between any two groups. The chi-square test was used for comparison of categorical data between groups, and a Pearson correlation analysis was also performed. Results There were significant differences in the levels of serum Cys C and urinary NGAL between the AKI group and the non-AKI group, as well as between the AKI group and the healthy control group ( all P < 0. 01) . AKI stage was determined for all AKI patients, and the AKI patients with a higher stage had significantly higher levels of serum Cys C and urinary NGAL than those with a lower stage ( all P < 0. 05) . Of all 56 AKI patients, 11 ( 19. 6% ) died; the patients who died had significantly higher levels of serum Cys C and urinary NGAL than those who survived ( t =-7. 742 and-3. 209, both P < 0. 01) . The correlation analysis showed that the levels of serum Cys C and urinary NGAL were negatively correlated with GFR ( r =-0. 915 and-0. 793, both P < 0. 01) . The levels of serum Cys C and urinary NGAL increased significantly and GFR decreased significantly with the increase in Child-Pugh class ( all P <0. 05) . Conclusion Combined measurement of serum Cys C and urinary NGAL can be used for the early diagnosis of AKI secondary to cirrhotic ascites and the evaluation of the severity and prognosis of AKI.
- liver cirrhosis /
- ascites /
- acute kidney injury /
- cystatin C /
- lipocalins /
- diagnosis

HTML全文

参考文献(18)

[1]WONG F.Acute kidney injury in liver cirrhosis:new definition and application[J].Clin Mol Hepatol, 2016, 22 (4) :415-422.

[2]BELCHER JM, GARCIA-TSAO G, SANYAL AJ, et al.Association of AKI with mortality and complications in hospitalized patients with cirrhosis[J].Hepatology, 2013, 57 (2) :753-762.

[3]WONG F, O'LEARY JG, REDDY KR, et al.New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection[J].Gastroenterology, 2013, 145 (6) :1280-1288.

[4]ANGELI P, GINESP, WONG F, et al.Diagnosis and management of acute kidney injury in patients with cirrhosis:revised consensus recommendations of the International Club of Ascites[J].J Hepatol, 2015, 62 (4) :968-974.

[5]JIA SF, LIU SR, ZHOU LY, et al.To explore the clinical significance of Cys-C testing for the elderly chronic renal failure early diagnosis[J].Chin J Lab Diag, 2013, 17 (10) :1834-1836. (in Chinese) 贾淑芳, 刘书蓉, 周琳瑶, 等.老年慢性肾功能衰竭早期诊断中血清胱抑素C检测的意义[J].中国实验诊断学, 2013, 17 (10) :1834-1836.

[6]PU CW, WANG BY, QIAO L, et al.Recent progress in research of biomarkers of acute kidney injury in liver cirrhosis[J].Chin J Hepatol, 2013, 21 (10) :796-798. (in Chinese) 蒲春文, 王炳元, 乔梁, 等.肝硬化并发急性肾损伤标志物的研究进展[J].中华肝脏病杂志, 2013, 21 (10) :796-798.

[7]XIMENES RO, FARIAS AQ, HELOU CM.Early predictors of acute kidney injury in patients with cirrhosis and bacterial infection:urinary neutrophil gelatinase-associated lipocalin and cardiac output as reliable tools[J].Kidney Res Clin Pract, 2015, 34 (3) :140-145.

[8]BARRETO R, ELIA C, SOLAE, et al.Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections[J].J Hepatol, 2014, 61 (1) :35-42.

[9]VERNA EC, BROWN RS, FARRAND E, et al.Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis[J].Dig Dis Sci, 2012, 57 (9) :2362-2370.

[10]RUNYON BA.AASLD Practice Guideline.Management of adult patients with ascites due to cirrhosis:update 2012[J/OL].Hepatology, 2013.http://www.aasld.org/practiceguidelines/Documents/ascitesupdate2013.pdf

[11]Kidney Disease:Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group.KDIGO clinical practice guideline for acute kidney injury[J].Kidney Int Suppl, 2012, 2 (Suppl 1) :1-138.

[12]AL-KHAFAJI A, NADIM MK, KELLUM JA.Hepatorenal disorders[J].Chest, 2015, 148 (2) :550-558.

[13]CHUNG MY, JUN DW, SUNG SA.Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis[J].Korean J Hepatol, 2010, 16 (3) :301-307.

[14]FRANCOZ C, GLOTZ D, MOREAU R, et al.The evaluation of renal function and disease in patients with cirrhosis[J].J Hepatol, 2010, 52 (4) :605-613.

[15]MISHRA J, MORI K, MA Q, et al.Neutrophil gelatinase-associated lipocalin:a novel early urinary biomarker for cisplatin nephrotoxicity[J].Am J Nephrol, 2004, 24 (3) :307-315.

[16]WU SK, WU Y, LUO WX, et al.The relativity of serum/urine neutrophil gelatinase-associated lipocalin and the outcome of patients of sepsis combined with acute kidney injury[J].J Clin Exp Med, 2016, 15 (13) :1291-1294. (in Chinese) 吴寿坤, 伍义, 罗文晓, 等.血清及尿中性粒细胞明胶酶相关脂质运载蛋白水平与脓毒症急性肾损伤患者肾功能转归的关系[J].临床和实验医学杂志, 2016, 15 (13) :1291-1294.

[17]CRUZ DN, de CAL M, GARZOTTO F, et al.Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population[J].Intensive Care Med, 2010, 36 (3) :444-451.

[18]ABERG F, LEMPINEN M, HOLLMEN M, et al.Neutrophil gelatinase-associated lipocalin associated with irreversibility of pre-liver transplant kidney dysfunction[J].Clin Transplant, 2014, 28 (8) :869-876.

施引文献

资源附件(0)

访问统计